Last updated: 24 March 2021 at 4:42pm EST

Matthew J Klaben Net Worth




The estimated Net Worth of Matthew J Klaben is at least $6.39 Milion dollars as of 22 March 2021. Matthew Klaben owns over 41,952 units of Sotera Health Co stock worth over $5,298,760 and over the last 18 years Matthew sold SHC stock worth over $1,095,786.

Matthew Klaben SHC stock SEC Form 4 insiders trading

Matthew has made over 10 trades of the Sotera Health Co stock since 2006, according to the Form 4 filled with the SEC. Most recently Matthew sold 41,952 units of SHC stock worth $1,095,786 on 22 March 2021.

The largest trade Matthew's ever made was selling 41,952 units of Sotera Health Co stock on 22 March 2021 worth over $1,095,786. On average, Matthew trades about 5,031 units every 191 days since 2006. As of 22 March 2021 Matthew still owns at least 327,286 units of Sotera Health Co stock.

You can see the complete history of Matthew Klaben stock trades at the bottom of the page.



What's Matthew Klaben's mailing address?

Matthew's mailing address filed with the SEC is C/O SOTERA HEALTH COMPANY, 9100 SOUTH HILLS BDVD, SUITE 300, BROADVIEW HEIGHTS, OH, 44147.

Insiders trading at Sotera Health Co

Over the last 4 years, insiders at Sotera Health Co have traded over $2,215,398,516 worth of Sotera Health Co stock. The most active insiders traders include Pincus & Co.Warburg Pincus ..., Pincus & Co.Warburg Pincus ... oraz James Neary. On average, Sotera Health Co executives and independent directors trade stock every 84 days with the average trade being worth of $132,007,108. The most recent stock trade was executed by Pincus & Co.Warburg Pincus ... on 6 September 2024, trading 15,000,000 units of SHC stock currently worth $225,450,000.



What does Sotera Health Co do?

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.



What does Sotera Health Co's logo look like?

Sotera Health Co logo

Complete history of Matthew Klaben stock trades at Chart Industries Inc i Sotera Health Co

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
22 Mar 2021 Matthew J Klaben
SVP, GC oraz Sekretariat
Sprzedaż 41,952 $26.12 $1,095,786
22 Mar 2021
327,286
2 Jan 2016 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 835 $17.96 $14,997
2 Jan 2016
29,022
2 Jan 2015 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 747 $34.27 $25,600
2 Jan 2015
27,678
14 Mar 2013 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 2,900 $27.74 $80,446
14 Mar 2013
25,895
14 Nov 2011 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 22,439 $12.16 $272,858
14 Nov 2011
33,287
1 Nov 2011 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 40,000 $12.16 $486,400
1 Nov 2011
30,848
3 Mar 2009 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Kupować 4,000 $5.80 $23,200
3 Mar 2009
14,000
13 Aug 2008 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 25,000 $12.16 $304,000
13 Aug 2008
28,000
12 Dec 2007 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Opcja Ćwiczenie 500 $12.16 $6,080
12 Dec 2007
3,000
25 Jul 2006 Matthew J Klaben
Wiceprezydent, Główny radca prawny oraz Sec
Kupować 2,500 $15.00 $37,500
25 Jul 2006
2,500


Sotera Health Co executives and stock owners

Sotera Health Co executives and other stock owners filed with the SEC include: